U.S. Government Fed Up With Pharmaceutical Prices – FDA To The Rescue?
June 7, 2011
PharmacyChecker.com
By Margaret Rode
In March of this year the FDA took the unusual step of allowing an “unapproved” compounded drug to remain on the market to explicitly make sure Americans could afford that product. That drug is hydroxyprogesterone caproate, branded by K-V Pharmaceuticals as Makena, the first FDA-approved drug to prevent the risk of preterm birth in certain women. Will more such government interventions continue in support of drug affordability? Read more